No parsed quarterly data available for Regencell Bioscience Holdings Ltd yet.
RGC operating cash flow (10-K history)
Regencell Bioscience Holdings Ltd reported operating cash flow of -$3.11M for fiscal year 2025. That is up 22.2% from -$4.00M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$390.99K (FY 2019) to -$3.11M. Figures come from the company's audited annual reports as filed with the SEC.
